TY - JOUR
T1 - Casein hydrolysate diet controls intestinal T cell activation, free radical production and microbial colonisation in NOD mice
AU - Emani, R
AU - Asghar, Muhammad Nadeem
AU - Toivonen, R
AU - Lauren, L
AU - Söderström, M
AU - Toivola, Diana
AU - Tol EAF, van
AU - Hänninen, A
PY - 2013
Y1 - 2013
N2 - Dietary and microbial factors and the gut immune system are important in autoimmune diabetes. We evaluated inflammatory activity in the whole gut in prediabetic NOD mice using ex vivo imaging of reactive oxygen and nitrogen species (RONS), and correlated this with the above-mentioned factors.NOD mice were fed a normal diet or an anti-diabetogenic casein hydrolysate (CH) diet. RONS activity was detected by chemiluminescence imaging of the whole gut. Proinflammatory and T cell cytokines were studied in the gut and islets, and dietary effects on gut microbiota and short-chain fatty acids were determined.Prediabetic NOD mice displayed high RONS activity in the epithelial cells of the distal small intestine, in conjunction with a proinflammatory cytokine profile. RONS production was effectively reduced by the CH diet, which also controlled (1) the expression of proinflammatory cytokines and colonisation-dependent RegIII gamma (also known as Reg3g) in ileum; (2) intestinal T cell activation; and (3) islet cytokines. The CH diet diminished microbial colonisation, increased the Bacteroidetes:Firmicutes ratio, and reduced lactic acid and butyric acid production in the gut.Epithelial RONS production and proinflammatory T cell activation appears in the ileum of NOD mice after weaning to normal laboratory chow, but not after weaning to an anti-diabetogenic CH diet. Our data suggest a link between dietary factors, microbial colonisation and mucosal immune activation in NOD mice.
AB - Dietary and microbial factors and the gut immune system are important in autoimmune diabetes. We evaluated inflammatory activity in the whole gut in prediabetic NOD mice using ex vivo imaging of reactive oxygen and nitrogen species (RONS), and correlated this with the above-mentioned factors.NOD mice were fed a normal diet or an anti-diabetogenic casein hydrolysate (CH) diet. RONS activity was detected by chemiluminescence imaging of the whole gut. Proinflammatory and T cell cytokines were studied in the gut and islets, and dietary effects on gut microbiota and short-chain fatty acids were determined.Prediabetic NOD mice displayed high RONS activity in the epithelial cells of the distal small intestine, in conjunction with a proinflammatory cytokine profile. RONS production was effectively reduced by the CH diet, which also controlled (1) the expression of proinflammatory cytokines and colonisation-dependent RegIII gamma (also known as Reg3g) in ileum; (2) intestinal T cell activation; and (3) islet cytokines. The CH diet diminished microbial colonisation, increased the Bacteroidetes:Firmicutes ratio, and reduced lactic acid and butyric acid production in the gut.Epithelial RONS production and proinflammatory T cell activation appears in the ileum of NOD mice after weaning to normal laboratory chow, but not after weaning to an anti-diabetogenic CH diet. Our data suggest a link between dietary factors, microbial colonisation and mucosal immune activation in NOD mice.
KW - Casein hydrolysate
KW - Guanine and cytosine profiling
KW - Gut immune system
KW - In vivo imaging system
KW - Laser capture microscopy
KW - Microbiota analysis
KW - Nonobese diabetic (NOD) mouse
KW - Reactive oxygen and nitrogen species
KW - dietary intervention
KW - Casein hydrolysate
KW - Guanine and cytosine profiling
KW - Gut immune system
KW - In vivo imaging system
KW - Laser capture microscopy
KW - Microbiota analysis
KW - Nonobese diabetic (NOD) mouse
KW - Reactive oxygen and nitrogen species
KW - dietary intervention
KW - Casein hydrolysate
KW - Guanine and cytosine profiling
KW - Gut immune system
KW - In vivo imaging system
KW - Laser capture microscopy
KW - Microbiota analysis
KW - Nonobese diabetic (NOD) mouse
KW - Reactive oxygen and nitrogen species
KW - dietary intervention
U2 - 10.1007/s00125-013-2941-x
DO - 10.1007/s00125-013-2941-x
M3 - Artikel
SN - 0012-186X
VL - 56
SP - 1781
EP - 1791
JO - Diabetologia
JF - Diabetologia
IS - 8
ER -